Russia announced Wednesday it had approved a second COVID-19 vaccine, as the country recorded a large daily increase in cases and switched to online classes for secondary school in the capital, Moscow.
The new vaccine completed early-stage trials in September and was developed by Siberia’s Vector Institute. The country approved its first vaccine in August. Currently, neither vaccine is in general circulation.
Russia’s coronavirus task force said it had recorded 14,231 new cases Wednesday, the most since the pandemic began, and 239 deaths. More than 4,500 of the new cases were in Moscow.
For more info, please go to http://www.globalnews.ca
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #COVID19 #coronavirus
Comments
Post a Comment